Interview 5 Apr 2021
Base Editing: The Next Frontier in Genome Editing Technology
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base…
Horizon Discovery
- Latest Posts
News and Trends 14 Jan 2020
Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing
Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene editing technology it has licensed…
Interview 1 Apr 2019
Chasing the Holy Grail of Cell Therapy
Biotech entrepreneur Darrin Disley, ex-CEO and co-founder of the successful Cambridge gene editing biotech Horizon Discovery, has a new quest…
In Depth 6 Feb 2018
CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could it be used as a…
ADVERTISEMENT
Infographics 21 Jun 2017
Check Out these 42 European SynBio Startups Reimagining the Industry
Synthetic biology, or synbio for short, is rapidly infiltrating multiple fields. From bioplastics to food technology and healthcare, these are…
News and Trends 27 Mar 2017
You Can Now Search Worldwide Genomic Data in a Single Platform
Access to data is still the main bottleneck for genomic researchers. Repositive has created a free online platform to solve…
Best in Biotech 30 Jan 2017
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an exciting entrepreneurial scene at the…
News and Trends 16 Jan 2017
The UK Steps Up its Game in Automated CRISPR Gene Editing
Horizon Discovery now has full access to CRISPR technology and will develop an automated gene editing platform in collaboration with…
News and Trends 5 Oct 2016
€365M deal for a Danish ‘DNA barcode’ Drug Screening Platform
The giant Amgen has offered Nuevolution €365M to develop oncology and neuroscience drugs. The small Danish Biotech claims to count with…
News and Trends 7 Sep 2016
Promising Boston-based CRISPR Startup hits up Horizon to fix Gene Misregulation
An American outfit from Third Rock Ventures, Fulcrum Therapeutics, has made a deal with Horizon to access its catalogue of genetic…
News and Trends 2 Mar 2016
New Joint Venture to Shake Up Immuno-Oncology in the UK
Avvinity Therapeutics is the new child of two UK Biotechs: Horizon Discovery and Centauri. The goal? To create the ultimate immuno-oncology toolbox…
News and Trends 28 Oct 2015
The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ
Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues. A UK expansion for Horizon…
News and Trends 8 Oct 2015
Rabbit Antibodies proven to be more specific than Mice in Immuno-oncology PD-L1 Research
Abcam is a Cambridge (UK) Biotech who have developed a monoclonal antibody (mAB) production platform from rabbits. This platform is…
News and Trends 16 Sep 2015
Desktop Genetics bags €1.87M from top UK business angels to change how you manage your CRIPSR experiments
Gene Editing has been made much easier thanks to CRISPR but managing your genome editing workflow can be a challenge. London-based…
News and Trends 13 Sep 2015
What happened this week? An award for Kymab, disappointment for Crowdfunding and some Wasps to save us!
Monday: A report said that the total value of crowdfunded Biotech projects from within the EU since 2010 is €23M. Tuesday: Researchers…
News and Trends 11 Sep 2015
Cambridge Love Triangle: Leading Biotechs Abcam and Horizon finally collaborate together
This is the story of how Abcam and Horizon fell in collaborative-biotech-love and finally came together to partner up on…
